Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SCLX on Nasdaq
Shares outstanding
8,418,919
Price per share
$12.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
759,753
Total reported value
$14,960,373
% of total 13F portfolios
0%
Share change
+135,193
Value change
+$3,311,361
Number of holders
79
Price from insider filings
$12.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.6% $87,504,000 4,800,000 Armistice Capital, LLC 30 Jun 2025
ORAMED PHARMACEUTICALS INC. 9.9% 0% $16,402,249 +$1,361,736 833,473 +9.1% Oramed Pharmaceuticals Inc. 30 Sep 2025

As of 30 Sep 2025, 79 institutional investors reported holding 759,753 shares of Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX). This represents 9% of the company’s total 8,418,919 outstanding shares.

Institutional Holders of Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,041 $12,713 -$497 $12.20 10
2025 Q3 759,753 $14,960,373 +$3,311,361 $19.68 79
2025 Q2 619,697 $3,649,759 +$3,564,553 $5.89 64
2025 Q1 42,004 $10,442 +$10,434 $0.25 4